Рубрики Mesh:
Острая болезнь
Взрослые
Антибактериальные средства - прием и дозировка
Антибактериальные средства - терапевтическое применение
Escherichia coli - действие лекарственных препаратов
Escherichia coli - выделение и очистка
Коли-инфекции - лекарственная терапия
Коли-инфекции - микробиология
Женский
Человек
Микробной чувствительности тесты
Лечения результатов анализ
Трометамол - прием и дозировка
Трометамол - терапевтическое применение
Мочевых путей инфекции - лекарственная терапия
Мочевых путей инфекции - микробиология
Журнальная статья
Обзор
Spivak L.G.
Rapoport L.M.
Platonova D.V.
Tsarichenko D.G.
Evdokimov M.S.
Demidko Y.L. Yu L
Enikeev D.V.
Rossolovsky A.N.
Department of Urology, Medical Faculty, I.M. Sechenov First MSMU of Minzdrav of Russia, Moscow, Russia.
LLC Family Polyclinic 4, Moscow, Russia.
Research Institute of Uronephrology and Human Reproductive Health.
Saratov state medical University. V. I. Razumovsky Ministry of health of Russia, Saratov, Russia.
Issues of spectrum and local sensitivity of E. coli in female patients with acute uncomplicated lower urinary tract infection a review of M. Seitz study and own observations
Текст визуальный электронный
Urologiia (Moscow, Russia : 1999)
№ 3 С. 58-62
2018
antibacterial therapy
cystitis
fosfomycin trometamol
resistance
sensitivity
uncomplicated lower urinary tract infections
Статья
Обзор
Acute Disease C23.550.291.125
Острая болезнь C23.550.291.125
Adult M01.060.116
Взрослые M01.060.116
Anti-Bacterial Agents administration & dosage D27.505.954.122.085
Anti-Bacterial Agents therapeutic use D27.505.954.122.085
Антибактериальные средства прием и дозировка D27.505.954.122.085
Антибактериальные средства терапевтическое применение D27.505.954.122.085
Escherichia coli drug effects B03.440.450.425.325.300 B03.660.250.150.180.100
Escherichia coli isolation & purification B03.440.450.425.325.300 B03.660.250.150.180.100
Escherichia coli действие лекарственных препаратов B03.440.450.425.325.300 B03.660.250.150.180.100
Escherichia coli выделение и очистка B03.440.450.425.325.300 B03.660.250.150.180.100
Escherichia coli Infections drug therapy C01.150.252.400.310.330
Escherichia coli Infections microbiology C01.150.252.400.310.330
Коли-инфекции лекарственная терапия C01.150.252.400.310.330
Коли-инфекции микробиология C01.150.252.400.310.330
Female
Женский
Humans B01.050.150.900.649.313.988.400.112.400.400
Человек B01.050.150.900.649.313.988.400.112.400.400
Microbial Sensitivity Tests E01.370.225.875.595 E05.200.875.595 E05.337.550.400
Микробной чувствительности тесты E01.370.225.875.595 E05.200.875.595 E05.337.550.400
Treatment Outcome E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
Лечения результатов анализ E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
Tromethamine administration & dosage D02.033.455.706.900
Tromethamine therapeutic use D02.033.455.706.900
Трометамол прием и дозировка D02.033.455.706.900
Трометамол терапевтическое применение D02.033.455.706.900
Urinary Tract Infections drug therapy C01.915 C12.050.351.968.892
Urinary Tract Infections microbiology C01.915 C12.050.351.968.892
Мочевых путей инфекции лекарственная терапия C01.915 C12.050.351.968.892
Мочевых путей инфекции микробиология C01.915 C12.050.351.968.892
Journal Article V02.600
Журнальная статья V02.600
Review V02.600.500 V02.912
Обзор V02.600.500 V02.912
Acute uncomplicated lower urinary tract infections (AULUTI) are one of the most common diseases in urological practice. The management of cystitis is commonly based on antibacterial therapy. Despite the high efficiency, inadequate prescription of antibiotics leads to an increase in microorganisms resistance. In light of these matters, the selection of antibacterial agents to which the sensitivity of bacteria is the highest is becoming increasingly challenging.